StockData
Synlogic, Inc. logo

Synlogic, Inc. (SYBX) shareholders

SYBXOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$1.07+0.07 (+7.00%)

Close on Oct 19, 2026Market cap $13.29MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
0.2%
0M of 12M shares
Institutional holders
1
0 new, 1 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Cable Car Capital, LP
Joint filing with Funicular Funds, LP (28.30%), Ma-Weaver Jacob (28.30%)
3,312,21928.30%13D (active) amendmentJul 28, 2026
Ma-Weaver Jacob
Joint filing with Funicular Funds, LP (28.30%), Cable Car Capital, LP (28.30%)
3,312,21928.30%13D (active) amendmentApr 2, 2026
Nea 14 Gp, Ltd
Joint filing with New Enterprise Associates 14, L.P. (25.00%), NEA Partners 14, L.P. (25.00%) and 3 more
2,922,77225.00%13D (active) amendmentJul 28, 2026
David Paolella
Joint filing with Baselake Partners, LP (9.70%), Baselake Management, LLC (9.70%)
1,140,0009.70%13G (passive)Jan 20, 2026
Kryzanowski, John A.733,4126.27%13G (passive) amendmentDec 31, 2024

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of SYBXValueChange% of portfolio
DRW Securities, LLC23,7630.19%$16.66K–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202610M0.2%0 / 00 / 10M0M
Q1 202620M0.2%0 / 01 / 220M7M
Q4 2025257M56.2%5 / 62 / 30M0M
Q3 2025237M54.3%7 / 44 / 30M0M
Q2 2025197M55.3%3 / 33 / 20M0M
Q1 2025187M55.4%1 / 33 / 00M0M
Q4 2024187M55.2%2 / 13 / 10M0M
Q3 2024177M55.7%2 / 14 / 10M0M
Q2 2024177M56.7%2 / 24 / 20M0M
Q1 2024177M56.6%2 / 54 / 93M1M
Q4 2023245M38.5%5 / 95 / 73M1M
Q3 2023273M21.7%27 / 00 / 03M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

1 funds held SYBX in Q2 2026, 0% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of SYBXValue% of fundAs of
Large-Cap Growth Portfolio5,3230.04%$3.73K0.00%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Mary Beth DooleySee Remarks below12,7440.10%Oct 31, 2025
Mohamad MakhzoumiDirector, 10% owner––Aug 14, 2026
Scott D. SandellDirector, 10% owner7,151,71358.39%Aug 14, 2026
Anthony A. Florence Jr.Director, 10% owner4,228,94034.52%Aug 14, 2026
New Enterprise Associates 14, L.P.Director, 10% owner2,114,37517.26%Aug 14, 2026
NEA Partners 14, L.P.Director, 10% owner––Aug 14, 2026
Nea 14 Gp, LtdDirector, 10% owner4,228,94034.52%Aug 14, 2026
James P. FlynnDirector15,0000.12%Apr 29, 2025
Richard P. SheaDirector15,5060.13%Apr 29, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Mary Beth Dooley
See Remarks below
Oct 29, 2025Sale−157$1.81$28412,744
James P. Flynn
Director
Apr 26, 2025Award+15,000––15,000
Richard P. Shea
Director
Apr 26, 2025Award+15,000––15,506
Mary Beth Dooley
See Remarks below
Apr 2, 2025Sale−144$1.20$17312,901
Mary Beth Dooley
See Remarks below
Feb 3, 2025Sale−2,107$1.33$2.80K13,045
Mary Beth Dooley
Head of Finance
Oct 29, 2024Sale−79$1.40$11115,152
Mary Beth Dooley
Head of Finance
Apr 2, 2024Sale−188$1.73$32515,231
Antoine Awad
Chief Operating Officer
Apr 2, 2024Sale−372$1.73$64433,859
Aoife Brennan
See Remarks, Director
Apr 3, 2023Sale(10b5-1 plan)−19,042$0.58$11.04K256,301
Antoine Awad
Chief Operating Officer
Apr 3, 2023Sale−6,438$0.58$3.73K74,732
Michael Vangsted Jensen
Chief Financial Officer
Apr 3, 2023Sale−2,553$0.58$1.48K46,947
Michael Vangsted Jensen
Chief Financial Officer
May 24, 2022Buy+9,500$1.12$10.64K39,500
Aoife Brennan
See Remarks, Director
Apr 4, 2022Sale(10b5-1 plan)−8,894$2.45$21.79K275,343
Antoine Awad
Chief Operating Officer
Apr 4, 2022Sale(10b5-1 plan)−2,650$2.45$6.49K81,170
Michael Vangsted Jensen
Chief Financial Officer
Mar 3, 2022Award+30,000––30,000
Aoife Brennan
See Remarks, Director
Feb 4, 2022Award+106,920––284,237
Antoine Awad
Chief Operating Officer
Feb 4, 2022Award+40,820––83,820
Chau Quang Khuong
Director
Apr 20, 2021Award+1,666,666$3.00$5.00M3,696,662
Capital GP VI LLC OrbiMed
Director
Apr 20, 2021Award+1,666,666$3.00$5.00M3,696,662
Antoine Awad
Chief Operating Officer
Mar 10, 2021Award+17,500––43,000
Richard J. Riese
Chief Medical Officer
Mar 10, 2021Award+17,500––39,000
Aoife Brennan
See Remarks, Director
Mar 10, 2021Award+71,250––177,317
Aoife Brennan
See Remarks, Director
Mar 10, 2020Award+46,300––106,067
Richard J. Riese
Chief Medical Officer
Mar 10, 2020Award+13,500––21,500
Richard P. Shea
Director
Dec 13, 2019Buy+7,500$2.74$20.55K7,500
Richard J. Riese
Chief Medical Officer
Sep 23, 2019Award+8,000––8,000
Scott Eric Plevy
Chief Scientific Officer
Sep 23, 2019Award+8,000––8,000
Aoife Brennan
See Remarks, Director
Sep 23, 2019Award+8,000––59,767
Paul Francis Miller
Chief Scientific Officer
Feb 13, 2019Sale(10b5-1 plan)−5,849$9.75$57.03K48,135
Paul Francis Miller
Chief Scientific Officer
Feb 12, 2019Sale(10b5-1 plan)−3,151$9.75$30.72K53,984
Paul Francis Miller
Chief Scientific Officer
Oct 18, 2018Sale(10b5-1 plan)−3,000$9.77$29.31K57,135
Paul Francis Miller
Chief Scientific Officer
Sep 18, 2018Sale(10b5-1 plan)−3,000$13.05$39.15K60,135
Paul Francis Miller
Chief Scientific Officer
Sep 5, 2018Sale(10b5-1 plan)−3,000$12.55$37.65K63,135
Paul Francis Miller
Chief Scientific Officer
Aug 30, 2018Sale(10b5-1 plan)−1,342$9.76$13.10K66,135
Paul Francis Miller
Chief Scientific Officer
Aug 29, 2018Sale(10b5-1 plan)−1,658$9.77$16.20K67,477
Paul Francis Miller
Chief Scientific Officer
Jul 18, 2018Sale(10b5-1 plan)−3,000$11.01$33.03K69,135
Paul Francis Miller
Chief Scientific Officer
Jun 20, 2018Sale(10b5-1 plan)−1,054$9.80$10.33K72,135
Paul Francis Miller
Chief Scientific Officer
Jun 20, 2018Sale(10b5-1 plan)−1,000$9.75$9.75K72,135
Paul Francis Miller
Chief Scientific Officer
Jun 19, 2018Sale(10b5-1 plan)−946$9.75$9.22K74,189
Capital GP VI LLC OrbiMed
Director
Jan 26, 2018Award+715,000$9.75$6.97M2,029,996
Michael Powell
Director
Jan 26, 2018Award+150,000$9.75$1.46M574,972
Chau Quang Khuong
Director
Jan 26, 2018Award+715,000$9.75$6.97M2,029,996
Nea 14 Gp, Ltd
10% owner
Jan 26, 2018Award+410,000$9.75$4.00M4,228,940
Patrick J. Kerins
10% owner
Jan 26, 2018Award+410,000$9.75$4.00M4,228,940
Peter W. Sonsini
10% owner
Jan 26, 2018Award+410,000$9.75$4.00M4,228,940
David M. Mott
10% owner
Jan 26, 2018Award+410,000$9.75$4.00M4,228,940
Peter J. Barris
10% owner
Jan 26, 2018Award+410,000$9.75$4.00M4,228,940
Ravi Viswanathan
10% owner
Jan 26, 2018Award+410,000$9.75$4.00M4,228,940
M. James Barrett
10% owner
Jan 26, 2018Award+410,000$9.75$4.00M4,228,940
Anthony A. Florence Jr.
10% owner
Jan 26, 2018Award+410,000$9.75$4.00M4,228,940
Scott D. Sandell
10% owner
Jan 26, 2018Award+410,000$9.75$4.00M4,228,940
Forest Baskett
10% owner
Jan 26, 2018Award+410,000$9.75$4.00M4,228,940
Jose-Carlos Gutierrez-Ramos
See Remarks, Director
Oct 2, 2017Gift−10,000––352,619
Peter J. Barris
10% owner
Aug 28, 2017Award+3,394,439––3,818,940
M. James Barrett
10% owner
Aug 28, 2017Award+3,394,439––3,818,940
Ravi Viswanathan
10% owner
Aug 28, 2017Award+3,394,439––3,818,940
Patrick J. Kerins
10% owner
Aug 28, 2017Award+3,394,439––3,818,940
Forest Baskett
10% owner
Aug 28, 2017Award+3,394,439––3,818,940
Scott D. Sandell
10% owner
Aug 28, 2017Award+3,394,439––3,818,940
Anthony A. Florence Jr.
10% owner
Aug 28, 2017Award+3,394,439––3,818,940

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
0.0%
From 0M shares
Short volume, 20 days
27.0%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Synlogic's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Brennan Aoife
Affiliate
Apr 22, 202488,293$161.58KApr 19, 2024Options
Brennan Aoife
Affiliate
Mar 21, 20246,868$11.88KMar 21, 2024Owned Shares

See a number that looks wrong?